Phenethylamine

Phenethylamine

SCHEMBL8026262

I.NCCc1ccccc1

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Phenethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 3/20 0.94
▸ LOXL2 Q9Y4K0 2/20 0.94
▸ TAAR1 Q96RJ0 2/20 0.94
▸ CYP2A6 P11509 1/20 0.94
▸ SMN1; SMN2 Q16637 1/20 0.94
▸ MAOA P21397 3/20 0.64
▸ MAOB P27338 3/20 0.59
▸ CYP1A2 P05177 1/20 0.58
▸ CYP2D6 P10635 1/20 0.58
▸ CYP2C19 P33261 1/20 0.58
▸ HTR6 P50406 2/20 0.56
▸ HTR2C P28335 1/20 0.54
▸ ALDH1A1 P00352 1/20 0.52
▸ HPGD P15428 1/20 0.52
▸ ALOX15 P16050 1/20 0.52
▸ ALOX12 P18054 1/20 0.52
▸ CASP1 P29466 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenethylamine SCHEMBL4485079 0.97 HTR2A (0.89) HTR2ALOXL2TAAR1CYP2A6SMN1; SMN2
Phenethylamine SCHEMBL31461079 0.97 HTR2A (0.89) HTR2ALOXL2TAAR1CYP2A6SMN1; SMN2
Phenethylamine SCHEMBL29775159 0.97 HTR2A (0.89) HTR2ALOXL2TAAR1CYP2A6SMN1; SMN2
Phenethylamine SCHEMBL8412421 0.97 HTR2A (0.89) HTR2ALOXL2TAAR1CYP2A6SMN1; SMN2
Phenethylamine SCHEMBL1331271 0.97 — —
Phenethylamine SCHEMBL1799333 0.97 HTR2A (1.00) HTR2ALOXL2TAAR1CYP2A6SMN1; SMN2
Phenethylamine SCHEMBL1332244 0.97 — —
Phenethylamine SCHEMBL1330939 0.97 — —
Phenethylamine SCHEMBL968 0.97 — —
Phenethylamine SCHEMBL27634208 0.97 HTR2A (1.00) HTR2ALOXL2TAAR1CYP2A6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1030 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122069876-A Double-passivation flexible perovskite solar cell and preparation method thereof 合肥工业大学 2026-05-19 — — CN claimed
CN-122054903-A Perovskite light-emitting and photovoltaic dual-functional device and preparation method thereof 郑州轻工业大学 2026-05-15 — — CN claimed
CN-122054799-A Vertical orientation 1D/3D perovskite film based on double-layer interface treatment, solar cell and preparation method 杭州电子科技大学 2026-05-15 — — CN claimed
CN-122054881-A Efficient and uniform perovskite passivation layer treatment method and solar cell 嘉兴大哲光能有限公司 2026-05-15 — — CN claimed
CN-122054887-A In-situ crystallization-passivation integrated preparation method of perovskite thin film, perovskite solar cell and preparation method thereof 常州亚玛顿股份有限公司 2026-05-15 — — CN claimed
CN-122028629-A Construction method of hybrid self-assembled monolayer for improving NiOx interface stability of semitransparent perovskite solar cell 中国科学技术大学 2026-05-12 — — CN claimed
US-20260101625-A1 PEROVSKITE SOLAR CELL AND ITS PREPARATION UNIV CITY HONG KONG (HK) 2026-04-09 — — US claimed
EP-4716435-A1 PEROVSKITE CELL AND PHOTOVOLTAIC MODULE Contemporary Amperex Technology Co., Limited (CN) 2026-03-25 — — EP claimed
CN-121586364-A Double-molecule synergistic passivation trans-perovskite solar cell and preparation method thereof 三峡大学 2026-02-27 — — CN claimed
US-20260033120-A1 PEROVSKITE CELL AND PHOTOVOLTAIC MODULE CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) 2026-01-29 — — US claimed
CN-111471351-A Perovskite ink, preparation method of perovskite thin film and display panel 深圳市华星光电半导体显示技术有限公司 2020-07-31 — — CN claimed
CN-109888110-B Preparation method of laminated perovskite solar cell 中国科学院大连化学物理研究所 2020-07-21 — — CN claimed
CN-111211248-A LED device based on lead-free perovskite thin film and preparation method thereof 南京理工大学 2020-05-29 — — CN claimed
CN-110993798-A Perovskite type solar cell based on cooperative post-treatment of multiple ammonium salts and preparation method thereof 北京大学 2020-04-10 — — CN claimed
US-20200035418-A1 PASSIVATION OF DEFECTS IN PEROVSKITE MATERIALS FOR IMPROVED SOLAR CELL EFFICIENCY AND STABILITY NUTECH VENTURES 2020-01-30 — — US claimed
WO-2019195194-A1 PEROVSKITE COMPOSITIONS COMPRISING MIXED SOLVENT SYSTEMS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2019-10-10 — — WO claimed
WO-2018152494-A1 PASSIVATION OF DEFECTS IN PEROVSKITE MATERIALS FOR IMPROVED SOLAR CELL EFFICIENCY AND STABILITY NUTECH VENTURES (US) 2018-08-23 — — WO claimed
US-5871579-A Two-step dipping technique for the preparation of organic-inorganic perovskite thin films INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1999-02-16 — — US claimed
US-5581192-A Conductive liquid compositions and electrical circuit protection devices comprising conductive liquid compositions EATON CORPORATION (US) 1996-12-03 — — US claimed
US-5471185-A Electrical circuit protection devices comprising conductive liquid compositions EATON CORPORATION (US) 1995-11-28 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260101625-A1 PEROVSKITE SOLAR CELL AND ITS PREPARATION NES, PPOX, SCO2 HTR2A 3595/4885LOXL2 2079/4885TAAR1 4763/4885
US-20260033120-A1 PEROVSKITE CELL AND PHOTOVOLTAIC MODULE SLC9A2, HCN4, CRY1 HTR2A 1128/4885LOXL2 1671/4885TAAR1 4227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback